相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MTOR inhibition attenuates DNA damage and apoptosis through autophagy-mediated suppression of CREB1
Ying Wang et al.
AUTOPHAGY (2013)
Radioimmunotherapy for peritoneal cancers
Christof Seidl et al.
IMMUNOTHERAPY (2013)
Tumour angiogenesis regulation by the miR-200 family
Chad V. Pecot et al.
NATURE COMMUNICATIONS (2013)
Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma
Dominique Werner et al.
CANCER MEDICINE (2013)
Prevention of β-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL
Yan Chen Shang et al.
AGING-US (2012)
Targeting disease through novel pathways of apoptosis and autophagy
Kenneth Maiese et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
The Role of Bcl-xL in Synergistic Induction of Apoptosis by Mapatumumab and Oxaliplatin in Combination with Hyperthermia on Human Colon Cancer
Xinxin Song et al.
MOLECULAR CANCER RESEARCH (2012)
Overexpression of S6 Kinase 1 in Brain Tumours Is Associated with Induction of Hypoxia-Responsive Genes and Predicts Patients' Survival
Heba M. S. Ismail
JOURNAL OF ONCOLOGY (2012)
Activation of the Phosphoinositide-3-Kinase and Mammalian Target of Rapamycin Signaling Pathways Are Associated With Shortened Survival in Patients With Malignant Peritoneal Mesothelioma
Sheelu Varghese et al.
CANCER (2011)
Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis
Kurt Van der Speeten et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival
Douglas C. Marchion et al.
CLINICAL CANCER RESEARCH (2011)
Requirement for ribosomal protein S6 kinase 1 to mediate glycolysis and apoptosis resistance induced by Pten deficiency
Preeti Tandon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Combination Intraperitoneal Chemotherapy Is Superior to Mitomycin C or Oxaliplatin for Colorectal Carcinomatosis In Vivo
Mark S. Cohen et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1)
Laura R. Pearce et al.
BIOCHEMICAL JOURNAL (2010)
Hydrogen peroxide inhibits mTOR signaling by activation of AMPKα leading to apoptosis of neuronal cells
Long Chen et al.
LABORATORY INVESTIGATION (2010)
Targeting mTOR globally in cancer Thinking beyond rapamycin
Boris Shor et al.
CELL CYCLE (2009)
Enhancing mTOR-targeted cancer therapy
Xuerong Wang et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Direct control of mitochondrial function by mTOR
Arvind Ramanathan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
mTOR inhibitors in the treatment of cancer
Angelica Fasolo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
BAD: undertaker by night, candyman by day
N. N. Danial
ONCOGENE (2008)
JNK signaling in apoptosis
D. N. Dhanasekaran et al.
ONCOGENE (2008)
Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation
Andrew Y. Choo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Sirolimus and intraoperative hyperthermic peritoneal chemoperfusion with mitomycin-C do not impair healing of bowel anastomoses
Oliver J. Wagner et al.
TRANSPLANT INTERNATIONAL (2008)
The effects of mTOR-Akt interactions on anti-apoptotic signaling in vascular endothelial cells
Olivier Dormond et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Current development of mTOR inhibitors as anticancer agents
Sandrine Faivre et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
An expanding role for mTOR in cancer
DA Guertin et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Antitumor activity of rapamycin in a transgenic mouse model of ErbB2-dependent human breast cancer
M Liu et al.
CANCER RESEARCH (2005)
Peritoneal carcinomatosis of colorectal cancer: incidence, prognosis, and treatment modalities
C Knorr et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2004)
JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins
F Tsuruta et al.
EMBO JOURNAL (2004)
Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial
GV Kornek et al.
ANNALS OF ONCOLOGY (2004)
Mitomycin C induces apoptosis and caspase-8 and-9 processing through a caspase-3 and Fas-independent pathway
F Pirnia et al.
CELL DEATH AND DIFFERENTIATION (2002)
Identification of a conserved motif required for mTOR signaling
SS Schalm et al.
CURRENT BIOLOGY (2002)
p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD
H Harada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Staurosporine inhibits phosphorylation of translational regulators linked to mTOR
AR Tee et al.
CELL DEATH AND DIFFERENTIATION (2001)
Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death
MC Wei et al.
SCIENCE (2001)
DNA-damaging agents cause inactivation of translational regulators linked to mTOR signalling
AR Tee et al.
ONCOGENE (2000)
分享论文
